
Asia Pacific Aortic Stent Graft Market Report and Forecast 2024-2032
Description
Asia Pacific Aortic Stent Graft Market Report and Forecast 2024-2032
Asia Pacific Aortic Stent Graft Market Report and Forecast 2024-2032
Asia Pacific Aortic Stent Graft Market Outlook
The global aortic stent graft market size was valued at USD 3.1 billion in 2023, with Asia Pacific holding a significant market share. The market is driven by the growing aging population and the rising demand for minimally invasive surgeries. It is expected to grow at a CAGR of 5.8% during the forecast period of 2024-2032, with the values likely to attain USD 5.2 billion by 2032.
Key Takeaways
- The prevalence of aortic aneurysms and dissections (AAD) is estimated to be around 1-3% in the general population. However, in the older age groups, the prevalence increases to 10%. The growing aging population in the Asia Pacific region is expected to directly impact market demand.
- LifeTech Scientific Corporation reported that revenue generated from the sales of stent grafts till December 2023 witnessed an increase by 11.2%, reflecting a rise in the adoption of the device for treatment interventions. This growing preference for endovascular repair using aortic stent grafts is anticipated to boost the Asia Pacific aortic stent graft market share.
- One of the major market trends is the surge in approvals of new and advanced aortic stent graft systems. In July 2023, Terumo Aortic’s Thoraflex Hybrid frozen elephant trunk (FET) device received approval from the Japanese Pharmaceuticals and Medical Devices Agency (PMDA) for the treatment of complex aortic arch disease.
Aortic stent grafts are medical devices that are used in the treatment of aortic aneurysms (bulges in the wall of the aorta). They are designed to reinforce the weakened area in the aorta and prevent rupture of the aneurysm. The aortic stent graft is placed using an endovascular procedure (Endovascular aneurysm repair or thoracic endovascular aneurysm repair), which is less invasive compared to open surgery. The rising patient inclination towards such minimally invasive surgeries is expected to drive the Asia Pacific aortic stent graft market growth. Moreover, the increasing advancements in imaging and manufacturing technologies are also contributing to the growing acceptance of this medical device.
The Asia Pacific region is characterized by a rising aging population, particularly in countries like Japan where 29.1% of the 125 million population is aged 65 or over . The prevalence of aortic aneurysms and dissections (AAD) is estimated to be around 1-3% in the general population. However, in the older age groups, the prevalence increases to 10%. As the population ages, the risk for cardiovascular diseases including aortic aneurysms is likely to rise, which is poised to fuel the Asia Pacific aortic stent graft market demand in the forecast period.
LifeTech Scientific Corporation , a Chinese manufacturer of minimally invasive interventional medical devices for cardio-cerebrovascular and peripheral vascular diseases, announced the 2023 annual results, revealing the successful penetration of the company’s medical device products at different market levels in China including aortic stent grafts. Further, it was reported that revenue generated was increased by 11.2% from the sales of stent grafts for the year ended 31 December 2023, indicating an increased adoption of the devices for treatment interventions. The growing preference for endovascular repair using aortic stent grafts due to low procedural morbidity and mortality rates is anticipated to augment the market share.
One of the major Asia Pacific aortic stent graft market trends is the surge in approvals of new and advanced aortic stent graft systems. In July 2023, stent graft manufacturer Terumo Aortic announced that its Thoraflex Hybrid frozen elephant trunk (FET) device has received approval from the Japanese Pharmaceuticals and Medical Devices Agency (PMDA) for the commercial sale of the product in Japan for the treatment of complex aortic arch disease. The single-use medical device comprises Gelweave polyester graft with a Nitinol self-expanding stent graft and is employed for the open surgical repair or replacement of diseased or damaged vessels in cases of aneurysm or dissection. The rising introduction of such innovative stent grafts facilitated by the presence of a supportive regulatory framework is expected to bolster market growth.
Asia Pacific Aortic Stent Graft Market Segmentation
Market Breakup by Product
- Abdominal Aortic Stent Grafts
- Thoracic Aortic Stent Grafts
- Hospitals
- Ambulatory Surgical Centres
- Others
- China
- Japan
- ASEAN
- Australia
- India
- Others
The key features of the market report include patent analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:
- Cook Medical, Inc.
- W.L. Gore & Associates
- MicroPort Scientific Corporation Inc.
- Medtronic Plc.
- Lombard Medical, Inc.
- Endologix, Inc.
- Terumo Corporation Inc.
- Cardinal Health Inc.
- Becton, Dickinson and Company
- CryoLife Inc.
FAQs
- What is the Asia Pacific aortic stent graft market forecast outlook for 2024-2032?
- What are the major factors aiding the Asia Pacific aortic stent graft market demand?
- What are the major Asia Pacific aortic stent graft market trends?
- What is the market segmentation based on the product?
- What are the major end users of the market?
- What is the market segmentation by countries?
- Who are the key players involved in the Asia Pacific aortic stent graft market?
Meta description
The Asia Pacific aortic stent graft market is poised for growth, driven by the expansion of the global market, which was valued at USD 3.1 billion in 2023 and is projected to grow at a CAGR of 5.8% during the forecast period of 2024-2032.
*Please Note:* The report will take 7 business days to complete, after order confirmation.
Table of Contents
140 Pages
- 1 Preface
- 1.1 Objectives of the Study
- 1.2 Key Assumptions
- 1.3 Report Coverage – Key Segmentation and Scope
- 1.4 Research Methodology
- 2 Executive Summary
- 3 Asia Pacific Aortic Stent Graft Market Overview
- 3.1 Asia Pacific Aortic Stent Graft Market Historical Value (2017-2023)
- 3.2 Asia Pacific Aortic Stent Graft Market Forecast Value (2024-2032)
- 4 Asia Pacific Aortic Stent Graft Market Landscape*
- 4.1 Asia Pacific Aortic Stent Graft: Developers Landscape
- 4.1.1 Analysis by Year of Establishment
- 4.1.2 Analysis by Company Size
- 4.1.3 Analysis by Region
- 4.2 Asia Pacific Aortic Stent Graft: Product Landscape
- 4.2.1 Analysis by Product
- 4.2.2 Analysis by Type
- 4.2.3 Analysis by Application
- 5 Asia Pacific Aortic Stent Graft Market Dynamics
- 5.1 Market Drivers and Constraints
- 5.2 SWOT Analysis
- 5.2.1 Strengths
- 5.2.2 Weaknesses
- 5.2.3 Opportunities
- 5.2.4 Threats
- 5.3 Porter’s Five Forces Analysis
- 5.3.1 Bargaining Power of Suppliers
- 5.3.2 Bargaining Power of Buyers
- 5.3.3 Threat of New Entrants
- 5.3.4 Threat of Substitutes
- 5.3.5 Degree of Rivalry
- 5.4 Key Demand Indicators
- 5.5 Key Price Indicators
- 5.6 Industry Events, Initiatives, and Trends
- 5.7 Value Chain Analysis
- 6 Asia Pacific Aortic Stent Graft Market Segmentation (2017-2032)
- 6.1 Asia Pacific Aortic Stent Graft Market (2017-2032) by Product
- 6.1.1 Market Overview
- 6.1.2 Abdominal Aortic Stent Grafts
- 6.1.3 Thoracic Aortic Stent Grafts
- 6.2 Asia Pacific Aortic Stent Graft Market (2017-2032) by End User
- 6.2.1 Market Overview
- 6.2.2 Hospitals
- 6.2.3 Ambulatory Surgical Centers
- 6.2.4 Others
- 6.3 Asia Pacific Aortic Stent Graft Market (2017-2032) by Countries
- 6.3.1 Market Overview
- 6.3.2 China
- 6.3.3 Japan
- 6.3.4 ASEAN
- 6.3.5 Australia
- 6.3.6 India
- 6.3.7 Others
- 7 China Aortic Stent Graft Market (2017-2032)
- 7.1 China of Aortic Stent Graft Market (2017-2032) by Product
- 7.1.1 Market Overview
- 7.1.2 Abdominal Aortic Stent Grafts
- 7.1.3 Thoracic Aortic Stent Grafts
- 7.2 China of Aortic Stent Graft Market (2017-2032) by End User
- 7.2.1 Market Overview
- 7.2.2 Hospitals
- 7.2.3 Ambulatory Surgical Centers
- 7.2.4 Others
- 8 Japan Aortic Stent Graft Market (2017-2032)
- 8.1 Japan Aortic Stent Graft Market (2017-2032) by Product
- 8.1.1 Market Overview
- 8.1.2 Abdominal Aortic Stent Grafts
- 8.1.3 Thoracic Aortic Stent Grafts
- 8.2 Japan Aortic Stent Graft Market (2017-2032) by End User
- 8.2.1 Market Overview
- 8.2.2 Hospitals
- 8.2.3 Ambulatory Surgical Centers
- 8.2.4 Others
- 9 ASEAN Aortic Stent Graft Market (2017-2032)
- 9.1 ASEAN Aortic Stent Graft Market (2017-2032) by Product
- 9.1.1 Market Overview
- 9.1.2 Abdominal Aortic Stent Grafts
- 9.1.3 Thoracic Aortic Stent Grafts
- 9.2 ASEAN Aortic Stent Graft Market (2017-2032) by End User
- 9.2.1 Market Overview
- 9.2.2 Hospitals
- 9.2.3 Ambulatory Surgical Centers
- 9.2.4 Others
- 10 Australia Aortic Stent Graft Market (2017-2032)
- 10.1 Australia Aortic Stent Graft Market (2017-2032) by Product
- 10.1.1 Market Overview
- 10.1.2 Abdominal Aortic Stent Grafts
- 10.1.3 Thoracic Aortic Stent Grafts
- 10.2 Australia Aortic Stent Graft Market (2017-2032) by End User
- 10.2.1 Market Overview
- 10.2.2 Hospitals
- 10.2.3 Ambulatory Surgical Centers
- 10.2.4 Others
- 11 India Aortic Stent Graft Market (2017-2032)
- 11.1 India Aortic Stent Graft Market (2017-2032) by Product
- 11.1.1 Market Overview
- 11.1.2 Abdominal Aortic Stent Grafts
- 11.1.3 Thoracic Aortic Stent Grafts
- 11.2 India Aortic Stent Graft Market (2017-2032) by End User
- 11.2.1 Market Overview
- 11.2.2 Hospitals
- 11.2.3 Ambulatory Surgical Centers
- 11.2.4 Others
- 12 Regulatory Framework
- 13 Patent Analysis
- 13.1 Analysis by Type of Patent
- 13.2 Analysis by Publication year
- 13.3 Analysis by Issuing Authority
- 13.4 Analysis by Patent Age
- 13.5 Analysis by CPC Analysis
- 13.6 Analysis by Patent Valuation
- 13.7 Analysis by Key Players
- 14 Funding and Investment Analysis
- 14.1 Analysis by Funding Instances
- 14.2 Analysis by Type of Funding
- 14.3 Analysis by Funding Amount
- 14.4 Analysis by Leading Players
- 14.5 Analysis by Leading Investors
- 14.6 Analysis by Geography
- 15 Partnership and Collaborations Analysis
- 15.1 Analysis by Partnership Instances
- 15.2 Analysis by Type of Partnership
- 15.3 Analysis by Leading Players
- 15.4 Analysis by Geography
- 16 Supplier Landscape
- 16.1 Market Share by Top 5 Companies
- 16.2 Cook Medical, Inc.
- 16.2.1 Financial Analysis
- 16.2.2 Product Portfolio
- 16.2.3 Demographic Reach and Achievements
- 16.2.4 Mergers and Acquisitions
- 16.2.5 Certifications
- 16.3 W.l. Gore & Associates
- 16.3.1 Financial Analysis
- 16.3.2 Product Portfolio
- 16.3.3 Demographic Reach and Achievements
- 16.3.4 Mergers and Acquisitions
- 16.3.5 Certifications
- 16.4 MicroPort Scientific Corporation Inc.
- 16.4.1 Financial Analysis
- 16.4.2 Product Portfolio
- 16.4.3 Demographic Reach and Achievements
- 16.4.4 Mergers and Acquisitions
- 16.4.5 Certifications
- 16.5 Medtronic Plc.
- 16.5.1 Financial Analysis
- 16.5.2 Product Portfolio
- 16.5.3 Demographic Reach and Achievements
- 16.5.4 Mergers and Acquisitions
- 16.5.5 Certifications
- 16.6 Lombard Medical, Inc.
- 16.6.1 Financial Analysis
- 16.6.2 Product Portfolio
- 16.6.3 Demographic Reach and Achievements
- 16.6.4 Mergers and Acquisitions
- 16.6.5 Certifications
- 16.7 Endologix, INC.
- 16.7.1 Financial Analysis
- 16.7.2 Product Portfolio
- 16.7.3 Demographic Reach and Achievements
- 16.7.4 Mergers and Acquisitions
- 16.7.5 Certifications
- 16.8 Terumo Corporation Inc.
- 16.8.1 Financial Analysis
- 16.8.2 Product Portfolio
- 16.8.3 Demographic Reach and Achievements
- 16.8.4 Mergers and Acquisitions
- 16.8.5 Certifications
- 16.9 Cardinal Health Inc.
- 16.9.1 Financial Analysis
- 16.9.2 Product Portfolio
- 16.9.3 Demographic Reach and Achievements
- 16.9.4 Mergers and Acquisitions
- 16.9.5 Certifications
- 16.10 Becton, Dickinson and Company
- 16.10.1 Financial Analysis
- 16.10.2 Product Portfolio
- 16.10.3 Demographic Reach and Achievements
- 16.10.4 Mergers and Acquisitions
- 16.10.5 Certifications
- 16.11 Cryolife Inc.
- 16.11.1 Financial Analysis
- 16.11.2 Product Portfolio
- 16.11.3 Demographic Reach and Achievements
- 16.11.4 Mergers and Acquisitions
- 16.11.5 Certifications
- 17 Asia Pacific Aortic Stent Graft – Distribution Model (Additional Insight)
- 17.1 Overview
- 17.2 Potential Distributors
- 17.3 Key Parameters for Distribution Partner Assessment
- 18 Key Opinion Leaders (KOL) Insights (Additional Insight)
- 19 Company Competitiveness Analysis (Additional Insight)
- 19.1 Very Small Companies
- 19.2 Small Companies
- 19.3 Mid-Sized Companies
- 19.4 Large Companies
- 19.5 Very Large Companies
- 20 Payment Methods (Additional Insight)
- 20.1 Government Funded
- 20.2 Private Insurance
- 20.3 Out-of-Pocket
- *Additional insights provided are customisable as per client requirements.
- * The coverage of the Market Landscape section depends on the data availability and may cover a minimum of 80% of the total market. The EMR team strives to make this section as comprehensive as possible.
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.